Arog Pharmaceuticals is a clinical stage biotechnology company developing targeted small molecules therapies for the treatment of cancer.
AROG Pharmaceuticals, LLC.
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/arog-pharmaceuticals-llc” connections=”true” suffix=””]
In May 2010, AROG entered into an exclusive agreement with Pfizer Inc., to acquire the worldwide development rights to Plarotinib/ARO-002/CP-868-596. Plarotinib was originally developed by Pfizer in partnership with OSI Pharmaceuticals Inc.